As of 2024-12-11, the Relative Valuation of Algernon Pharmaceuticals Inc (AGN.CN) is (0.01) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 CAD, the upside of Algernon Pharmaceuticals Inc based on Relative Valuation is -107.9%.
The range of the Relative Valuation is (0.00) - (0.01) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.00) - (0.01) | (0.01) |
| Upside | -106.3% - -109.5% | -107.9% |
| Date | P/E |
| 2024-11-29 | -0.67 |
| 2024-11-28 | -0.72 |
| 2024-11-27 | -0.67 |
| 2024-11-25 | -0.67 |
| 2024-11-22 | -0.67 |
| 2024-11-21 | -0.63 |
| 2024-11-20 | -0.67 |
| 2024-11-19 | -0.63 |
| 2024-11-15 | -0.63 |
| 2024-11-14 | -0.63 |
| 2024-11-13 | -0.67 |
| 2024-11-12 | -0.67 |
| 2024-11-11 | -0.67 |
| 2024-11-08 | -0.72 |
| 2024-11-07 | -0.72 |
| 2024-11-06 | -0.72 |
| 2024-11-05 | -0.72 |
| 2024-11-01 | -0.72 |
| 2024-10-31 | -0.67 |
| 2024-10-30 | -0.67 |
| 2024-10-29 | -0.67 |
| 2024-10-28 | -0.67 |
| 2024-10-24 | -0.72 |
| 2024-10-23 | -0.72 |
| 2024-10-22 | -0.76 |
| 2024-10-21 | -0.72 |
| 2024-10-18 | -0.72 |
| 2024-10-17 | -0.72 |
| 2024-10-16 | -0.72 |
| 2024-10-15 | -0.63 |
| 2024-10-11 | -0.67 |
| 2024-10-10 | -0.63 |
| 2024-10-09 | -0.67 |
| 2024-10-08 | -0.72 |
| 2024-10-07 | -0.67 |
| 2024-10-04 | -0.69 |
| 2024-10-03 | -0.67 |
| 2024-10-02 | -0.67 |
| 2024-10-01 | -0.67 |
| 2024-09-30 | -0.76 |
| 2024-09-27 | -0.76 |
| 2024-09-26 | -0.76 |
| 2024-09-25 | -0.72 |
| 2024-09-24 | -0.76 |
| 2024-09-23 | -0.76 |
| 2024-09-20 | -0.72 |
| 2024-09-19 | -0.76 |
| 2024-09-18 | -0.76 |
| 2024-09-17 | -0.80 |
| 2024-09-16 | -0.84 |